Provides customized laboratory and clinical manufacture services to pharmaceutical and allied industries

j03372685.jpg (27396 bytes)j0337252.jpg (13932 bytes)j0337233.jpg (22421 bytes)j0337256.jpg (17479 bytes)j0337250.jpg (13983 bytes)j0337284.jpg (17172 bytes)j0337286.jpg (20616 bytes)

homebutton.bmp (13278 bytes)
productbutton.bmp (13278 bytes)analytbutton.bmp (13278 bytes)microbutton.bmp (13278 bytes)clinicalbutton.bmp (13278 bytes)regulatorybutton.bmp (13278 bytes)
capabilitiesbutton.bmp (13278 bytes)newsbutton.bmp (13278 bytes)careerbutton.bmp (13278 bytes)directionsbutton.bmp (13278 bytes)
linksbutton.bmp (13278 bytes)

 

-SL PHARMA LABS, INC. NEWS-

***

Upcoming Tradeshows 2008

SL Pharma Labs, Inc. will be exhibiting at the following tradeshows in 2008  Please visit us at our booths

Contract Pharma Contracting & Outsourcing Conference (September 25-26)- at the Hyatt Regency in New Brunswick, New Jersey

PDA Conference on the Development and Regulation of Clinical Trial Supplies (November 10-11)- Boston, MA

AAPS Annual Meeting (November 16-20), in Atlanta, GA- Booth No. 1836

Announcement-  July 2007

 SL Pharma Labs, Inc. is pleased to announce that it, once again, has successfully completed both Pre-Approval and GMP-Compliant Inspections by the FDA during June 2007. No 483 issued.

 Indeed, we take immense pride in stating that SL Pharma Labs, Inc., during its entire history of over 12 years, has consistently maintained its excellent track record of successful FDA inspections with no 483; attesting the unparalleled continuing commitment of the company’s management and staff to high quality and full compliance with GMP regulations.  

 

***

Aseptic Processing Facility for Clinical Manufacture of Parenterals and Other Sterile Dosage Forms

November 2005

As a part of continuing improvement and expansion of pharmaceutical and product development services, SL Pharma Labs, Inc. is pleased to announce that it has upgraded and expanded its Aseptic Processing facility for the manufacture of clinical supplies of parenterals, intranasals & other sterile drug products. The new facility is fully supported by well-equipped analytical and microbiological laboratories for all in-process and final product release testing.